Immunic reported $-22.81M in EBIT for its fiscal quarter ending in June of 2024.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 2.64B 116M Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Grifols EUR 411.56M 15.51M Sep/2025
Immunic USD -22.81M 756K Jun/2024
Insmed USD -249.71M 11.64M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
OraSure Technologies USD -6M 13.22M Sep/2024
Quidel USD -37.3M 82.5M Dec/2025
Ultragenyx Pharmaceutical USD -114M 56.89M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024